scholarly article | Q13442814 |
P356 | DOI | 10.1002/CNCR.26497 |
P698 | PubMed publication ID | 22020536 |
P50 | author | Nicola J. Armstrong | Q80566668 |
P2093 | author name string | Alan Wilson | |
Douglas W Henderson | |||
Sonja Klebe | |||
Brian McCaughan | |||
Kim Griggs | |||
Sarah Maltby | |||
Bridget Condon | |||
Steven Chuan-Hao Kao | |||
P2860 | cites work | Tetraethylammonium block of water flux in Aquaporin-1 channels expressed in kidney thin limbs of Henle's loop and a kidney-derived cell line | Q24292688 |
The aquaporin family of molecular water channels | Q24561944 | ||
Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype | Q28475905 | ||
Role of aquaporin water channels in pleural fluid dynamics | Q28508607 | ||
Role of aquaporin and sodium channel in pleural water movement | Q28509770 | ||
Estimation of predictive accuracy in survival analysis using R and S-PLUS. | Q33289347 | ||
Aquaporin water channels and lung physiology | Q33898997 | ||
Lung edema clearance: 20 years of progress: invited review: role of aquaporin water channels in fluid transport in lung and airways | Q34998571 | ||
Prognostic factors for mesothelioma | Q36329808 | ||
Aquaporins--new players in cancer biology | Q36661699 | ||
Aquaporin water channels in mammals | Q37351562 | ||
Aquaporin-1 water channel protein in lung: ontogeny, steroid-induced expression, and distribution in rat. | Q37354860 | ||
Future developments in the management of malignant pleural mesothelioma | Q37449036 | ||
Roles for novel pharmacological blockers of aquaporins in the treatment of brain oedema and cancer | Q37536320 | ||
Validation of tissue microarray technology in malignant pleural mesothelioma. | Q38412580 | ||
Survival of pleural malignant mesothelioma in Italy: a population-based study | Q38454393 | ||
Overexpression of AQP5, a putative oncogene, promotes cell growth and transformation | Q38501372 | ||
Thymidylate synthase but not excision repair cross-complementation group 1 tumor expression predicts outcome in patients with malignant pleural mesothelioma treated with pemetrexed-based chemotherapy. | Q39898457 | ||
Gene expression profiling: does it add predictive accuracy to clinical characteristics in cancer prognosis? | Q40248150 | ||
Pathophysiology of the aquaporin water channels | Q41117792 | ||
Tissue and serum EGFR as prognostic factors in malignant pleural mesothelioma | Q43116656 | ||
Pemetrexed in the treatment of malignant mesothelioma: results from an expanded access program in Germany. | Q43264264 | ||
Physiological importance of aquaporin water channels | Q46830033 | ||
Complete penetration of antibodies into vibratome sections after glutaraldehyde fixation and ethanol treatment: light and electron microscopy for neuropeptides | Q48413537 | ||
Malignant mesothelioma in Australia, 1945-2000. | Q50693526 | ||
Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy. | Q51399880 | ||
High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. | Q51536892 | ||
Survival from rare cancer in adults: a population-based study | Q54006928 | ||
Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin | Q57890679 | ||
Microvessel overexpression of aquaporin 1 parallels bone marrow angiogenesis in patients with active multiple myeloma | Q61876285 | ||
Predictive accuracy and explained variation in Cox regression | Q73717782 | ||
Malignant mesothelioma | Q80961479 | ||
Diagnosis of epithelial mesothelioma using tree-based regression analysis and a minimal panel of antibodies | Q83201291 | ||
P433 | issue | 11 | |
P304 | page(s) | 2952-2961 | |
P577 | publication date | 2011-10-21 | |
P1433 | published in | Cancer | Q326041 |
P1476 | title | Aquaporin 1 is an independent prognostic factor in pleural malignant mesothelioma | |
P478 | volume | 118 |
Q34278435 | A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice |
Q90455050 | Aquaporin 1 suppresses apoptosis and affects prognosis in esophageal squamous cell carcinoma |
Q59101133 | Aquaporin-1 expression in proliferative vitreoretinopathy and in epiretinal membranes |
Q28387194 | Biomarkers and prognostic factors for mesothelioma |
Q55459882 | Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on. |
Q35189370 | Blockade of aquaporin 1 inhibits proliferation, motility, and metastatic potential of mesothelioma in vitro but not in an in vivo model |
Q64097845 | Decreased expression of aquaporin 1 correlates with clinicopathological features of patients with cervical cancer |
Q31090122 | Elevated AQP1 Expression Is Associated With Unfavorable Oncologic Outcome in Patients With Hilar Cholangiocarcinoma |
Q33740721 | Expression and prognostic value of aquaporin 1, 3 in cervical carcinoma in women of Uygur ethnicity from Xinjiang, China |
Q64071672 | Genetic polymorphisms in aquaporin 1 as risk factors for malignant mesothelioma and biomarkers of response to cisplatin treatment |
Q50421336 | Immunohistochemical Expression of Aquaporin-1 in Fluoro-Edenite-Induced Malignant Mesothelioma: A Preliminary Report. |
Q42728294 | Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis? |
Q38585167 | Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma |
Q37090803 | Radical surgery for malignant pleural mesothelioma: have we identified the appropriate selection tools? |
Q47163115 | The Effect of Aquaporin 1-Inhibition on Vasculogenic Mimicry in Malignant Mesothelioma |
Q38953649 | The over-expression of aquaporin-1 alters erythroid gene expression in human erythroleukemia K562 cells |
Q40668409 | Usefulness of Aquaporin 1 as a Prognostic Marker in a Prospective Cohort of Malignant Mesotheliomas. |